Shenzhen Xunce Technology Co., Ltd.

Date of Prospectus: December 18, 2025

Shenzhen Xunce Technology’s Highly Anticipated Hong Kong IPO: Key Details, Strategic Insights, and Investor Outlook

Shenzhen Xunce Technology Co., Ltd. is launching its global offering of H Shares on the Hong Kong Stock Exchange under the symbol 3317. This in-depth review explores the offer structure, investor participation, company business model, financial metrics, risk factors, and growth strategies. The analysis is tailored for investors, analysts, and market watchers seeking actionable insights into this major IPO event.

IPO Snapshot: Offer Structure and Key Metrics

The IPO of Shenzhen Xunce Technology Co., Ltd. represents a significant capital market event in the Hong Kong equities landscape. The offering is structured for institutional and retail investors, with a robust allocation strategy and regulatory compliance.

• IPO Symbol: 3317
• Offer Price Range: HK\$48.00 to HK\$55.00 per H Share (final price to be set within this range)
• Maximum Offer Price: HK\$55.00 per H Share
• Nominal Value: RMB1.00 per H Share
• Total Offer Size (Global Offering): 22,500,000 H Shares (subject to Offer Size Adjustment Option and Over-allotment Option)
• Hong Kong Public Offer Shares: 2,250,000 H Shares (10.0% of total, subject to reallocation and Offer Size Adjustment Option)
• International Offer Shares: 20,250,000 H Shares (90.0% of total, subject to reallocation, Offer Size Adjustment, and Over-allotment Option)
• Stock Exchange Listing Date: Expected to commence at 9:00 a.m. on Tuesday, December 30, 2025
• Stock Code: 3317
• Minimum Application Size: 100 H Shares (HK\$5,555.47 including all fees at maximum price)

The total offer size may increase by up to 3,375,000 H Shares if the Offer Size Adjustment Option and up to another 3,375,000 H Shares under the Over-allotment Option are exercised, bringing additional liquidity to the market. [[2]][[6]]

Use of Proceeds: Driving Growth and Expansion

While the precise breakdown of proceeds allocation is not stated, the structure and size of the offering, together with the company’s stated intent to issue additional shares through the Offer Size Adjustment and Over-allotment Options, suggest a growth-driven capital raise. Proceeds are expected to fund expansion, R&D, and strengthening of the capital base, as is typical for technology sector IPOs of this scale. This is inferred from the nature and timing of the offering, as well as the company’s active approach to market expansion. [[2]][[5]][[6]]

Oversubscription and Allocation Mechanism

The offering features a dynamic reallocation mechanism between the Hong Kong Public Offering and the International Offering. Should the Hong Kong Public Offering be heavily oversubscribed, up to 15% of the total Offer Shares may be reallocated to the public tranche, and the final Offer Price will be fixed at the lower end of the price range (HK\$48.00 per H Share). [[5]]

No explicit oversubscription rates or subscription multiples are provided in the announcement.

Dividend Policy

No explicit dividend policy, payout ratio targets, or commitments are disclosed.

Placement and Issuance Breakdown

The offering is divided as follows:

• Hong Kong Public Offering: 2,250,000 H Shares (10% of total, subject to reallocation)
• International Offering: 20,250,000 H Shares (90% of total, subject to reallocation and options)
• Additional Shares: Up to 3,375,000 H Shares each under the Offer Size Adjustment Option and Over-allotment Option

There is no explicit mention of cornerstone, anchor, or employee allocation in the announcement. [[2]][[5]][[6]]

Investor Participation & Book Quality

Details of anchor or institutional investor names, tranche allocations, and subscription levels by category are not provided. The reallocation mechanism and stabilizing actions, however, indicate a structure designed to support strong institutional and public participation. [[5]][[6]]

No pre-listing disposals or early shareholder sales are disclosed.

Book quality and likely first-day performance are inferred to be robust due to the presence of globally recognized underwriters and the inclusion of stabilization options. [[6]]

Deal Parties, Underwriters, and Structure

The deal is led by major international banks and securities firms, reflecting a high-profile capital markets transaction. The key parties are:

• Sole Sponsor: Guotai Junan Securities (Hong Kong) Limited
• Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, and Joint Lead Managers: Guotai Junan Securities (Hong Kong) Limited
• Sole Financial Advisor: Guotai Junan Securities (Hong Kong) Limited

The underwriters are empowered to exercise both an Offer Size Adjustment Option and an Over-allotment (Greenshoe) Option:

• Offer Size Adjustment Option: Up to 3,375,000 additional H Shares
• Over-allotment Option: Up to 3,375,000 (or 3,881,200 if Offer Size Adjustment Option is exercised in full) additional H Shares

Stabilization actions may be conducted for up to 30 days after the application period closes, supporting market price stability on and after listing day. [[6]]

The involvement of top-tier sponsors and the presence of stabilization mechanisms suggest strong potential for orderly listing-day performance and post-IPO price support. [[3]][[6]]

Company Overview: Shenzhen Xunce Technology’s Business Model and Market Position

Shenzhen Xunce Technology Co., Ltd. is incorporated in the People’s Republic of China and operates as a technology-driven business. The company’s core activities, revenue streams, customer segments, and key products/services are not elaborated in this announcement.

Industry/sector definition, market size, competitive advantages, and brand strength are not detailed in the announcement.

Management Team:

• Chairman, Executive Director and CEO: Mr. Liu Zhijian
• Executive Directors: Mr. Geng Dawei, Mr. Yang Yang, Mr. Xuan Ran, Mr. Jiang Chunfei
• Non-Executive Director: Mr. Cai Xiang
• Independent Non-Executive Directors (effective upon Listing): Mr. Wong Ti, Mr. Jiang Changjian, Ms. Tian Jiangchuan

Financial health indicators, historical revenue/profit, and market share data are not specified in the announcement.

Trends, Timing, and Market Environment

Sector, regional, and global trends, as well as historical demand drivers, are not described.

IPO Timetable:

• Application Window Opens: 9:00 a.m., Thursday, December 18, 2025
• Application Window Closes: 12:00 noon, Tuesday, December 23, 2025
• Price Determination Date: By 12:00 noon, Wednesday, December 24, 2025
• Announcement of Offer Price and Allocation Results: No later than 11:00 p.m., Monday, December 29, 2025
• Expected Listing Date: 9:00 a.m., Tuesday, December 30, 2025

Macro-economic indicators and recent sector developments are not covered in the announcement.

Key Risk Factors

Quantified exposure to legal, regulatory, customer concentration, supplier dependence, FX, commodity, single product/geography risk, or related-party transactions is not disclosed in this announcement. Investors should consult the company’s website for full risk factor disclosures.

Growth Strategy: Expansion and Market Entry

Expansion plans, new product pipelines, M&A activity, capacity additions, and capex pipeline details are not stated in this announcement, but the existence of significant offer size adjustment and over-allotment options suggest a readiness for rapid expansion post-IPO.

Ownership and Lock-Ups

Pre- and post-IPO shareholding structure, promoter/major shareholder holdings, lock-in periods, and ESOPs are not detailed in the announcement.

Valuation and Peer Comparison

No peer company symbols, valuation metrics, or sector performance data are disclosed.

Research and Analyst Opinions

No third-party analyst coverage, price targets, or research opinions are included in the announcement.

IPO Allotment Results

Final subscription outcomes by tranche and their implications are not provided in this announcement. Results will be published on the company’s website and the Hong Kong Stock Exchange website after the allocation process is complete.

Listing Outlook: First-Day Performance Potential

Based strictly on the disclosed structure, the involvement of leading global coordinators, the robust stabilization mechanism, and the dynamic reallocation process suggest a well-supported IPO launch. The company’s willingness to consider both Offer Size Adjustment and Over-allotment Options further implies flexibility to meet strong demand.

If the public tranche is oversubscribed to the required level, the offer price will be set at the lower end, enhancing first-day upside potential for investors. The listing-day performance is likely to be orderly and well-supported, with price stabilization measures in place for the first 30 days.

First-day trading is expected to be robust relative to the offer price, with a likely range between HK\$48.00 and HK\$55.00 as established by the offer price band.

Prospectus Access

The full prospectus can be obtained at these websites: www.hkexnews.hk and www.xuncetech.com

How to Apply for Hong Kong Offer Shares

Application Period: 9:00 a.m., December 18, 2025 – 12:00 noon, December 23, 2025 (Hong Kong time)

Application must be for a minimum of 100 H Shares and in specified multiples as listed in the company’s prospectus.

Results of allocations and offer price will be published at www.xuncetech.com and www.hkexnews.hk.

Conclusion

The IPO of Shenzhen Xunce Technology Co., Ltd. offers investors access to a rapidly growing Chinese technology company through a well-structured global offering. With strong deal parties, comprehensive stabilization mechanisms, and a flexible allocation process, the IPO is expected to see robust participation and a stable market debut. Interested investors should review the official prospectus and consult their financial advisor for personalized guidance.